Diseases of the Colon & Rectum

, Volume 35, Issue 11, pp 1057–1065 | Cite as

Postoperative adjuvant radiotherapy in Astler-Coller Stages B2 and C rectal cancer

  • Reiping Tang
  • Jeng-Yi Wang
  • Jinn-Shiun Chen
  • Chung-Rong Chang-Chien
  • Siun-Eng Lin
  • Stephen Leung
  • Hong-Arh Fan
Original Contributions


Between 1979 and 1983, 127 patients with Stages B2 or C rectal cancer treated with surgery plus postoperative adjuvant radiotherapy (RT group) and 122 patients treated with surgery alone (S group) were compared to evaluate the effect of postoperative radiotherapy on survival and disease recurrence. Each group was stratified into subgroups according to stage and tumor differentiation as follows: Subgroups BW (Stage B2 and well-differentiated tumor), BM (Stage B2 and moderately differentiated tumor), CW (Stage C and well-differentiated tumor), CM (Stage C and moderately differentiated tumor), and P (poorly differentiated tumor). Ninety-five percent of the patients were followed until death or, if alive, to five years after surgery. Postoperative radiotherapy was associated with a reduced five-year survival rate in Subgroup BW (67vs.87 percent;P=0.02). In the remaining subgroups of the RT group, there was a statistically insignificant trend toward a worse survival rate (56vs.65 percent, 47vs. 64percent, 41vs.46 percent, and 50vs.36 percent for Subgroups BM, CW, CM, and P, respectively). The local failure rates for the S group and RT group were 10vs.23 percent (P=0.15) in Subgroup BW, 32vs.21 percent (P=0.4) in Subgroup BM, 24vs.25 percent (P=0.6) in Subgroup CW, and 18vs.18 percent (P=0.6) in Subgroup CM, respectively. Eight percent (9/127) had severe or life-threatening radiation-related complications. Postoperative adjuvant radiotherapy alone did not improve the survival of patients with Stages B2 or C rectal cancers. It may have led to worsened survival in the subgroup of patients with well-differentiated Stage B2 rectal cancer.

Key words

Rectal adenocarcinoma Radiotherapy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lofgren ET, Waugh JM, Dockerty NB. Local recurrence of carcinoma after anterior resection of the rectum and the sigmoid. Arch Surg 1957;74:825–38.Google Scholar
  2. 2.
    Gilbertsen VA. Adenocarcinoma of the rectum: incidence and locations of recurrent tumor following present-day operations performed for cure. Ann Surg 1960;151:340–8.Google Scholar
  3. 3.
    Floyd CE, Corley RG, Cohn I Jr. Local recurrence of carcinoma of the colon and rectum. Am J Surg 1965;109:153–7.PubMedGoogle Scholar
  4. 4.
    Gunderson LL, Sosin H. Area of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum: clinicopathological correlation and implications for adjuvant therapy. Cancer 1974;34:1278–92.PubMedGoogle Scholar
  5. 5.
    Moosa AR, Ree PC, Marks JE, Levin B, Platz CE. Factors influencing local recurrence after abdominoperineal resection for cancer of the rectum and rectosigmoid. Br J Surg 1975;62:727–30.PubMedGoogle Scholar
  6. 6.
    Cass AW, Million RR, Pfaff WW. Pattern of recurrence following surgery alone for adenocarcinoma of the colon and rectum. Cancer 1976;37:2861–5.PubMedGoogle Scholar
  7. 7.
    Gibert SG. Symptomatic local tumor failure following abdominoperineal resection. Int J Radiat Oncol Biol Phys 1978;4:801–7.PubMedGoogle Scholar
  8. 8.
    Rao AR, Kagan AR, Chan PM, Gilbert HA, Hassbaum H, Hintz BL. Patterns of recurrence following curative resection alone for adenocarcinoma of the rectum and sigmoid colon. Cancer 1981;150:331–5.Google Scholar
  9. 9.
    Rich T, Gunderson LL, Lew R, Galdibini JJ, Cohen AM, Donaldson G. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 1983;52:1327–9.Google Scholar
  10. 10.
    Pilipshen SH, Heiweil M, Quan SH, Sternberg SS, Enker WE. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 1984;53:1354–62.PubMedGoogle Scholar
  11. 11.
    McDermott FT, Hughes ES, Pihl E, Johnson WR, Price AB. Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patients. Br J Surg 1985;72:34–7.PubMedGoogle Scholar
  12. 12.
    Vlasak JW, Wagnaer D, Passaro E Jr, Wilson SE. Local recurrence after curative resection of rectal cancer: comparison of low anterior resection and abdominoperineal resection. J Surg Oncol 1989;41:326–9.Google Scholar
  13. 13.
    Beart RW, Martin JK, Gunderson LL. Management of recurrent rectal cancer. Mayo Clin Proc 1986;61:448–50.PubMedGoogle Scholar
  14. 14.
    Zucali R, Gardani G, Bolterrani F. Adjuvant postoperative radiotherapy in locally advanced rectal and rectosigmoid cancer. Tumori 1980;65:595–600.Google Scholar
  15. 15.
    Hoskins RB, Gunderson LL, Dosoretz DE,et al. Adjuvant postoperative radiotherapy in carcinoma of the rectum and rectosigmoid. Cancer 1985;55:61–71.PubMedGoogle Scholar
  16. 16.
    Tepper JE, Cohen AM, Wood WC, Orlow EL, Hedberg SE. Postoperative radiation therapy of rectal cancer. Int J Radiat Oncol Biol Phys 1987;13:5–10.PubMedGoogle Scholar
  17. 17.
    Vigliotti A, Rich TA, Romsdahl MM, Withers HR, Oswald MJ. Postoperative adjuvant radiotherapy for adenocarcinoma of the rectum and rectosigmoid. Int J Radiat Oncol Biol Phys 1987;13:999–1006.PubMedGoogle Scholar
  18. 18.
    Fisher B, Wolmark B, Rockette H,et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R01. J Natl Cancer Inst 1988;80:21–9.PubMedGoogle Scholar
  19. 19.
    Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985;312:1465–72.Google Scholar
  20. 20.
    Gastrointestinal Tumor Study Group. Survival after postoperative combination treatments of rectal cancer. N Engl J Med 1986;315:1294–5.Google Scholar
  21. 21.
    Balslev I, Pederson M, Teglbjaerg PS,et al. Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. Cancer 1986;58:22–8.PubMedGoogle Scholar
  22. 22.
    Astler VB, Coller FA. The prognosis significance of direct extension of carcinomas of the colon and rectum. Ann Surg 1954;139:846–51.PubMedGoogle Scholar
  23. 23.
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457–81.Google Scholar
  24. 24.
    Mantel H, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719–48.PubMedGoogle Scholar
  25. 25.
    Jones DJ, Zaloudik J, James RD, Haboubi N, Moore M, Schofield PF. Predicting local recurrence of carcinoma of the rectum after preoperative radiotherapy and surgery. Br J Surg 1989;76:1172–5.PubMedGoogle Scholar
  26. 26.
    Schild SE, Martenson JA Jr, Gunderson LL,et al. Postoperative adjuvant therapy of rectal cancer: an analysis of disease control, survival, and prognostic factors. Int J Radiat Oncol Biol Phys 1989;17:55–62.PubMedGoogle Scholar
  27. 27.
    Leff EI, Shaver JO, Hoexter B,et al. Anastomotic recurrence after low anterior resection: stapled vs. hand-sewn. Dis Colon Rectum 1985;28:164–7.PubMedGoogle Scholar
  28. 28.
    Turunen MJ, Peltokallio P. Surgical results in 657 patients with colorectal cancer. Dis Colon Rectum 1983;26:606–12.PubMedGoogle Scholar
  29. 29.
    Dunning EJ, Jones TE, Hazard JB. Carcinoma of the rectum: study of factors influencing survival following combined abdominoperineal resection of the rectum. Ann Surg 1951;138:166–73.Google Scholar
  30. 30.
    Chung CK, Zaino RJ, Stryker JA. Colorectal carcinoma: evaluation of histopathologic grade and factors influencing prognosis. J Surg Oncol 1982;21:143–8.PubMedGoogle Scholar
  31. 31.
    Warneke J, Petrelli NJ, Herrera L. Local recurrence after sphincter-saving resection for rectal adenocarcinoma. Am J Surg 1989;158:3–5.CrossRefPubMedGoogle Scholar
  32. 32.
    Morson BC, Vaughan EG, Bussey HJR. Pelvic recurrence after excision of rectum for carcinoma. BMJ 1963;2:13–8.Google Scholar
  33. 33.
    McGinnes K, Florence J, Penny R. The effect of radiotherapy on the natural killer (NK)-cell activity of cancer patients. J Clin Immunol 1987;7:210–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Onsrud M, Thorsby E. Long-term changes in natural killer activity after external pelvic irradiation. Int J Radiat Oncol Biol Phys 1981;7:609–14.Google Scholar
  35. 35.
    De Ruysscher D, Waer M, Vandeputte M, van der Schueren E. Immunologic changes after loco-regional radiotherapy and fractionated total body irradiation (TBI) in mice. Int J Radiat Oncol Biol Phys 1989;17:1237–45.PubMedGoogle Scholar
  36. 36.
    Gastrointestinal Tumor Study Group. Toxicity associated with adjuvant postoperative therapy for adenocarcinoma of the rectum. Cancer 1986;57:1130–4.Google Scholar
  37. 37.
    Pahlman L, Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 1990;211:187–95.PubMedGoogle Scholar
  38. 38.
    Sugarbaker P. Intrapelvic prosthesis to prevent injury of small intestine with high dosage pelvic irradiation. Surg Gynecol Obstet 1983;157:269–71.PubMedGoogle Scholar
  39. 39.
    Gunderson LL, Russell AH, Llewellyn HJ, Doppke KP, Tepper JE. Treatment planning for colorectal cancer: radiation and surgical techniques and value of small bowel films. Int J Radiat Oncol Biol Phys 1985;11:1379–93.PubMedGoogle Scholar
  40. 40.
    Devereux DF, Eisenstat T, Zinkin L. The safe and effective use of postoperative radiation therapy in modified Astler Coller stage C3 rectal cancer. Cancer 1989;63:2393–6.PubMedGoogle Scholar
  41. 41.
    MRC Working Party. The evaluation of low-dose preoperative x-ray therapy in the management of operable rectal cancer: results of a randomly controlled trial. Br J Surg 1984;71:21–5.Google Scholar
  42. 42.
    Mendenhall WM, Bland KI, Rout WR, Pfaff WW, Million RR, Copeland EM. Clinically resectable adenocarcinoma of the rectum treated with preoperative irradiation and surgery. Dis Colon Rectum 1988;31:287–90.PubMedGoogle Scholar
  43. 43.
    Gerard A, Berrod J-L, Pene F,et al. Interim analysis of a phase III study on preoperative radiation therapy in resectable rectal carcinoma: trial of the Gastrointestinal Tract Cancer Cooperative Group of the European Organization for Research on Treatment of Cancer. Cancer 1985;55:2373–9.PubMedGoogle Scholar
  44. 44.
    Gunderson LL, Collins R, Earle JD,et al. Adjuvant treatment of rectal cancer: randomized prospective study of irradiation ± chemotherapy; a NCCTG, Mayo Clinic study (abstract). Int J Radiat Oncol Biol Phys 1986;12(Suppl 1):169.Google Scholar
  45. 45.
    Smith DE, Muff NS, Shetabi H, Stutz FH, Eiesland H. Postoperative adjuvant chemotherapy and radiotherapy for cancer of the large bowel and rectum. Am J Surg 1989;157:508–12.CrossRefPubMedGoogle Scholar
  46. 46.
    Grem JL. Current treatment approaches in colorectal cancer. Semin Oncol 1991;18(Suppl 1):17–26.Google Scholar
  47. 47.
    Krook JE, Moertel CG, Gunderson LL,et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709–15.PubMedGoogle Scholar
  48. 48.
    NIH Concensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990; 264:1444–50.Google Scholar
  49. 49.
    Hoover HC Jr, Hanna MG Jr. Active immunotherapy in colorectal cancer. Semin Surg Oncol 1989;5:436–40.PubMedGoogle Scholar

Copyright information

© American Society of Colon and Rectal Surgeons 1992

Authors and Affiliations

  • Reiping Tang
    • 1
  • Jeng-Yi Wang
    • 1
  • Jinn-Shiun Chen
    • 1
  • Chung-Rong Chang-Chien
    • 1
  • Siun-Eng Lin
    • 1
  • Stephen Leung
    • 2
  • Hong-Arh Fan
    • 1
  1. 1.Colorectal Section, Department of SurgeryChang Gung Memorial HospitalTaipeiTaiwan
  2. 2.Department of Radiation OncologyChang Gung Memorial HospitalTaipeiTaiwan

Personalised recommendations